NIC (I), povorcitinib (II), golidocitinib (III) and filgotinib (IV) are some examples of JAK1 inhibitors used in the treatment of some cancers, inflammatory diseases such as rheumatoid arthritis and various skin conditions13, (Fig. 1). The gene discussed is JAK1; the disease is cancer.